Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
Dal Mas C, Nani JV, Noto C, Yonamine CM, da Cunha GR, Mansur RB, Ota VK, Belangero SI, Cordeiro Q, Kapczinski F, Brietzke E, Bressan RA, Gadelha A, Hayashi MAF.
Dal Mas C, et al.
Schizophr Res. 2019 Jun;208:202-208. doi: 10.1016/j.schres.2019.02.021. Epub 2019 Mar 8.
Schizophr Res. 2019.
PMID: 30857875